LecturaInvestigaciónRadarMarco de inversión
Iniciar sesión / Registrarse
← Volver a la lectura
TemaEditorial de DisconfirmAIActualizado 2026-10-22 16:59

英伟达生物计算拓展

4 pasos3 piezas4 Fuentes

英伟达正加速渗透生命科学领域,试图通过开源模型与硬件集群构建AI制药基础设施。2026年10月,英伟达联合华盛顿大学医学蛋白质设计研究所(IPD)发布RFD4-Proteina开源模型,宣称其计算设计成功率优于基线,并已与亚马逊、OpenAI等伙伴集成。同期,英伟达宣布与西门子医疗合作推进自适应放疗,并与罗氏达成扩大GPU集群协议以建设“混合云AI工厂”。此外,港股上市公司金斯瑞生物科技确认将与英伟达启动全球初创企业大赛,连接计算能力与湿实验验证。争议在于:尽管英伟达强调AI代理可缩短研发周期,但行业仍质疑纯计算预测能否替代传统实验瓶颈,且大规模部署面临数据隐私与监管合规挑战。

Cómo llegó hasta aquí

  1. 2026-03-16

    瑞士药企罗氏宣布与英伟达扩大合作,新增2,176个Blackwell GPU,旨在打造业界最大的混合云AI工厂以加速药物开发。

    fiercebiotech.com ↗
  2. 2026-10-21

    英伟达在GTC柏林发布RFD4-Proteina开源蛋白质设计模型,并宣布与西门子医疗合作开发下一代自适应放疗系统。

    nvidianews.nvidia.com ↗
  3. 2026-10-22

    英伟达官方频道发布视频,展示Lila Sciences如何利用NVIDIA Nemotron和Agent Toolkit构建自主实验室工作流。

    youtube.com ↗
  4. 2026-10-22

    英伟达研究团队与华盛顿大学IPD联合发布视频,详解RFD4-Proteina如何从计算机模拟推进至实验室蛋白质设计。

    youtube.com ↗

Lo que aún está pendiente

  • RFD4-Proteina在真实世界药物发现中的临床转化率是否显著高于传统方法?
  • 英伟达与金斯瑞等合作伙伴的生态模式能否有效解决AI设计与湿实验验证之间的脱节问题?
  • 随着AI深入医疗核心环节,监管机构对算法辅助诊断和治疗规划的审批标准将如何演变?
Iniciar sesión / Registrarse
LecturaInvestigaciónRadarMarco de inversión

Fuentes

  • nvidianews.nvidia.comNVIDIA Newsroom↗
  • fiercebiotech.comFierce Biotech↗
  • jiemian.com界面新闻↗
  • developer.nvidia.comNVIDIA Developer Blog↗

Cobertura en este tema

  • NVIDIA and IPD: Showcasing How AI Moves from Computer Models to Lab Protein Design2026-10-22Noticias

    NVIDIA Research and the University of Washington's Institute for Protein Design (IPD) released a video detailing the RFD4-Proteina project. Led by Nobel Laureate David Baker, the collaboration demonstrates how AI-generated protein designs are transitioned from computer models into laboratory testing, including work on enzymes that break down pesticides.

  • NVIDIA video: Lila Sciences' AI agents and automated labs for drug discovery2026-10-22Noticias

    NVIDIA's official channel released a video detailing how biotech firm Lila Sciences uses NVIDIA Nemotron and Agent Toolkit to build experimental plans, filters candidates via millions of virtual experiments using BioNeMo, and validates them with robotic instruments in its AI Science Factory. The resource illustrates the specific workflow connecting AI agents to autonomous labs.

  • NVIDIA Releases RFD4-Proteina Open Model for Protein Design, Claims Higher Success Rates Than Baselines2026-10-21Noticias

    NVIDIA launches RFD4-Proteina to accelerate drug discovery and partners with Siemens Healthineers on adaptive radiotherapy, showcasing AI's expansion into life sciences.